RT Journal Article
SR Electronic
T1 Estimate of airborne transmission of SARS-CoV-2 using real time tracking of health care workers
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.07.15.20154567
DO 10.1101/2020.07.15.20154567
A1 Hota, Bala
A1 Stein, Brian
A1 Lin, Michael
A1 Tomich, Alex
A1 Segreti, John
A1 Weinstein, Robert A.
YR 2020
UL http://medrxiv.org/content/early/2020/07/16/2020.07.15.20154567.abstract
AB BACKGROUND Whether and to what degree SARS-CoV-2 is spread via the airborne route is unknown. Using data collected from health care worker interactions with hospitalized patients with COVID-19 illness, we calculated the transmissibility of SARS-CoV-2 via the airborne route.OBJECTIVES/METHODS Healthcare worker interaction with SARS-CoV-2 infected patients were tracked using a real time location system between March 18 and March 31. A value for q, the transmissibility expressed as quanta per hour, was estimated using a well-established model for airborne transmission.RESULTS SARS-CoV-2 infection prevalence among tracked HCWs was 2.21% (0.07-4.35). Transmissibility was estimated to be 0.225 quanta per hour, well below other well-characterized airborne pathogens. Simulations demonstrated that risk of infection is substantially reduced with increased ventilation of rooms.CONCLUSIONS Overall, our findings suggest that SARS-CoV-2 is not well transmitted via the airborne route in controlled conditions. We speculate that SARS-CoV-2 may be only opportunistically airborne, with most transmission occurring via droplet methods.One Sentence Summary We calculated the airborne transmissibility (q) of SARS-CoV-2 and the impact of masks and ventilation in a hospital setting.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding was used for the development of this work.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Rush University Medical Center Institutional Review BoardAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData and code for analyses can be found at: Hota, Bala, Stein, Brian, & Tomich, Alex. (2020). Data for manuscript Estimate of airborne transmission of SARS-CoV-2 using real time tracking of healthcare workers. [Data set]. Zenodo. http://doi.org/10.5281/zenodo.3934582 http://doi.org/10.5281/zenodo.3934582